Background: Established randomized trial-based parameters for acute ischemic stroke group patients into generic treatment groups, leading to attempts using various artificial intelligence (AI) methods to directly correlate patient characteristics to outcomes and thereby provide decision support to stroke clinicians. We review AI-based clinical decision support systems in the development stage, specifically regarding methodological robustness and constraints for clinical implementation.
Methods: Our systematic review included full-text English language publications proposing a clinical decision support system using AI techniques for direct decision support in acute ischemic stroke cases in adult patients. We (1) describe data and outcomes used in those systems, (2) estimate the systems' benefits compared with traditional stroke diagnosis and treatment, and (3) reported concordance with reporting standards for AI in healthcare.
Results: One hundred twenty-one studies met our inclusion criteria. Sixty-five were included for full extraction. In our sample, utilized data sources, methods, and reporting practices were highly heterogeneous.
Conclusions: Our results suggest significant validity threats, dissonance in reporting practices, and challenges to clinical translation. We outline practical recommendations for the successful implementation of AI research in acute ischemic stroke treatment and diagnosis.
Keywords: artificial intelligence; decision support; humans; intelligence; ischemic stroke.